Peak6 Investments LLC Eli Lilly & CO Call Options Transaction History

Peak6 Investments LLC

$43.5 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $33.7 Million - $41.9 Million	43,600 Added 17.32%	295,300 $262 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $57.3 Million - $71.8 Million	79,000 Added 45.74%	251,700 $228 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $69.9 Million - $93.5 Million	118,000 Added 215.72%	172,700 $134 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $22.3 Million - $26.3 Million	-42,400 Reduced 43.67%	54,700 $31.9 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $20.3 Million - $28 Million	46,800 Added 93.04%	97,100 $52.2 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $6.7 Million - $8.96 Million	-19,100 Reduced 27.52%	50,300 $23.6 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $37.4 Million - $43.9 Million	-120,300 Reduced 63.42%	69,400 $23.8 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $10.3 Million - $12 Million	-31,900 Reduced 14.4%	189,700 $69.4 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $36.2 Million - $41.2 Million	122,000 Added 122.49%	221,600 $71.7 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $334,476 - $392,724	1,200 Added 1.22%	99,600 $32.3 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $3.97 Million - $4.93 Million	16,898 Added 20.73%	98,400 $28.2 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $4.59 Million - $5.69 Million	20,402 Added 33.39%	81,502 $22.5 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $5.5 Million - $6.76 Million	-24,800 Reduced 28.87%	61,100 $14.1 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $16.9 Million - $21.9 Million	-93,700 Reduced 52.17%	85,900 $19.7 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $8.51 Million - $11 Million	-51,800 Reduced 22.39%	179,600 $33.6 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $25.2 Million - $33.4 Million	193,400 Added 508.95%	231,400 $39.1 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $30.5 Million - $35.3 Million	-208,800 Reduced 84.6%	38,000 $5.62 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $28.8 Million - $34.7 Million	211,100 Added 591.32%	246,800 $40.5 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $2.21 Million - $2.74 Million	18,600 Added 108.77%	35,700 $4.95 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $267,300 - $331,075	-2,500 Reduced 12.76%	17,100 $2.25 Million
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $2.9 Million - $3.16 Million	-27,200 Reduced 58.12%	19,600 $2.19 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $24.2 Million - $28.2 Million	-218,300 Reduced 82.35%	46,800 $5.19 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $21.1 Million - $24.9 Million	-190,000 Reduced 41.75%	265,100 $34.4 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $19 Million - $21.3 Million	-179,600 Reduced 28.3%	455,100 $52.7 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $54.5 Million - $68.1 Million	634,700 New	634,700 $68.1 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.2 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.7 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.9 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$27 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account